ScholarIQanswers from OpenAlex

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance

PaperCitations, authors & open-access status

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance have?

ScholarIQcitation count

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance has 34 citations in the OpenAlex counts ScholarIQ stores.

When was Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance published?

ScholarIQyear

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance has 2012 year in the ScholarIQ index.

What is the open-access status of Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

ScholarIQoa status

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance has closed oa status in the ScholarIQ index.

What is the DOI of Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

ScholarIQdoi

The DOI for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is on the source record.

What is the PMID of Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

ScholarIQpmid

The PMID for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is on the source record.

What is the OpenAlex record for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

ScholarIQopenalex

The OpenAlex for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial